MedPath

Assessment of the Efficacy of Preoperative Endocrine Therapy of Letrozole in Postmenopausal Patients with Hormone-sensitive Breast cancer of Stage IIA to IIB

Phase 2
Conditions
Postmenopausal Breast Cancer
Registration Number
JPRN-UMIN000000881
Lead Sponsor
Department of Breast and Thyroid Surgery, Kawasaki Medical School
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Female
Target Recruitment
45
Inclusion Criteria

Not provided

Exclusion Criteria

1.Under chemotherapy and hormone therapy(for tumors) 2.Invasive carcinoma of other organs(less than 5 years after the last treatment) 3.With past history of breast cancer 4.Synchronous bilateral breast cancer 5.Under treatment with the drugs that may influence on the conditions of sex hormone

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath